FDA approves new drug regimen for TB
The Food and Drug Administration (FDA) has approved new oral three-drug regimen for the extensively-drug resistant tuberculosis (XDR-TB), estimated to have a mortality rate …
TB
Connect The Dots
The Food and Drug Administration (FDA) has approved new oral three-drug regimen for the extensively-drug resistant tuberculosis (XDR-TB), estimated to have a mortality rate …
